Comparison of the radiolabeled PSMA-inhibitor <sup>111</sup>In-PSMA-617 and the radiolabeled GRP-R antagonist <sup>111</sup>In-RM2 in primary prostate cancer samples.

Schollhammer, Romain; De Clermont Gallerande, Henri; Yacoub, Mokrane; Quintyn Ranty, Marie-Laure; Barthe, Nicole; Vimont, Delphine; Hindié, Elif; Fernandez, Philippe; Morgat, Clément

Comparison of the radiolabeled PSMA-inhibitor ¹¹¹In-PSMA-617 and the radiolabeled GRP-R antagonist ¹¹¹In-RM2 in primary prostate cancer samples.

Schollhammer, Romain; De Clermont Gallerande, Henri; Yacoub, Mokrane; Quintyn Ranty, Marie-Laure; Barthe, Nicole; Vimont, Delphine; Hindié, Elif; Fernandez, Philippe; Morgat, Clément.

Afiliação

Schollhammer R; Nuclear Medicine Department, University Hospital of Bordeaux, Place Amélie Raba Léon, 33000, 33076, Bordeaux, France. romain.scho@gmail.com.
De Clermont Gallerande H; University of Bordeaux, INCIA, UMR5287, 33400, Talence, France. romain.scho@gmail.com.
Yacoub M; CNRS, INCIA, UMR5287, 33400, Talence, France. romain.scho@gmail.com.
Quintyn Ranty ML; Nuclear Medicine Department, University Hospital of Bordeaux, Place Amélie Raba Léon, 33000, 33076, Bordeaux, France.
Barthe N; Department of Pathology, University Hospital of Bordeaux, 33076, Bordeaux, France.
Vimont D; Department of Pathology, University Hospital of Toulouse, 31000, Toulouse, France.
Hindié E; BioTis, Inserm U1026, Bordeaux, France.
Fernandez P; University of Bordeaux, INCIA, UMR5287, 33400, Talence, France.
Morgat C; CNRS, INCIA, UMR5287, 33400, Talence, France.

EJNMMI Res ; 9(1): 52, 2019 Jun 03.

Article em En | MEDLINE | ID: mdl-31161459

Palavras-chave

GRP-R; PSMA; Prostate cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: EJNMMI Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google